Erythropoietin and Neonatal Neuroprotection

Overview

Journal Clin Perinatol

Date 2015 Aug 8

PMID 26250911

Citations 56

Authors

Sandra E Juul

Gillian C Pet

Affiliations

Soon will be listed here.

Abstract

Certain groups of neonates are at high risk of developing long-term neurodevelopmental impairment and might be considered candidates for neuroprotective interventions. This article explores some of these high-risk groups, relevant mechanisms of brain injury, and specific mechanisms of cellular injury and death. The potential of erythropoietin (Epo) to act as a neuroprotective agent for neonatal brain injury is discussed. Clinical trials of Epo neuroprotection in preterm and term infants are updated.

Citing Articles

Neurogenesis and glial impairments in congenital hydrocephalus: insights from a BioGlue-induced fetal lamb model.

Karakaya D, Lampe K, Encinas J, Duru S, Peiro L, Oge H Fluids Barriers CNS. 2025; 22(1):20.

PMID: 39994758 PMC: 11849300. DOI: 10.1186/s12987-025-00630-3.

Hypoxic-Ischemic Encephalopathy: Pathogenesis and Promising Therapies.

Yang M, Wang K, Liu B, Shen Y, Liu G Mol Neurobiol. 2024; 62(2):2105-2122.

PMID: 39073530 DOI: 10.1007/s12035-024-04398-9.

Emerging therapeutic strategies in hypoxic-ischemic encephalopathy: a focus on cognitive outcomes.

Marques K, Rodrigues V, Balduci C, Montes G, Barradas P, Cunha-Rodrigues M Front Pharmacol. 2024; 15:1347529.

PMID: 38469401 PMC: 10925695. DOI: 10.3389/fphar.2024.1347529.

Brain Injury Outcomes after Adjuvant Erythropoietin Neuroprotection for Moderate or Severe Neonatal Hypoxic-Ischemic Encephalopathy: A Report from the HEAL Trial.

Wisnowski J, Monsell S, Bluml S, Goodman A, Li Y, Comstock B Dev Neurosci. 2023; 46(5):285-296.

PMID: 37906983 PMC: 11249061. DOI: 10.1159/000534618.

The Latest Evidence of Erythropoietin in the Treatment of Glaucoma.

Lin T, Lai Y, Chen Y, Lu D Int J Mol Sci. 2022; 23(24).

PMID: 36555679 PMC: 9784015. DOI: 10.3390/ijms232416038.

References

Boland B, Nixon R . Neuronal macroautophagy: from development to degeneration. Mol Aspects Med. 2006; 27(5-6):503-19. DOI: 10.1016/j.mam.2006.08.009. View

Wu Y, Lynch J, Nelson K . Perinatal arterial stroke: understanding mechanisms and outcomes. Semin Neurol. 2005; 25(4):424-34. DOI: 10.1055/s-2005-923536. View

Hintz S, Kendrick D, Stoll B, Vohr B, Fanaroff A, Donovan E . Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics. 2005; 115(3):696-703. DOI: 10.1542/peds.2004-0569. View

Cho Y, Kim G, Park S, Sim J, Won Y, Hwang C . Erythropoietin promotes oligodendrogenesis and myelin repair following lysolecithin-induced injury in spinal cord slice culture. Biochem Biophys Res Commun. 2011; 417(2):753-9. DOI: 10.1016/j.bbrc.2011.12.029. View

McQuillen P, Ferriero D . Selective vulnerability in the developing central nervous system. Pediatr Neurol. 2004; 30(4):227-35. DOI: 10.1016/j.pediatrneurol.2003.10.001. View

Lodygensky G, Vasung L, Sizonenko S, Huppi P . Neuroimaging of cortical development and brain connectivity in human newborns and animal models. J Anat. 2010; 217(4):418-28. PMC: 2992417. DOI: 10.1111/j.1469-7580.2010.01280.x. View

Back S . Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management. Clin Perinatol. 2014; 41(1):1-24. PMC: 3947650. DOI: 10.1016/j.clp.2013.11.001. View

Kidokoro H, Neil J, Inder T . New MR imaging assessment tool to define brain abnormalities in very preterm infants at term. AJNR Am J Neuroradiol. 2013; 34(11):2208-14. PMC: 4163698. DOI: 10.3174/ajnr.A3521. View

Xiong Y, Mahmood A, Qu C, Kazmi H, Zhang Z, Noguchi C . Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J Neurotrauma. 2009; 27(1):205-15. PMC: 2824224. DOI: 10.1089/neu.2009.1001. View

10.

Wu Y, Escobar G, Grether J, Croen L, Greene J, Newman T . Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003; 290(20):2677-84. DOI: 10.1001/jama.290.20.2677. View

11.

Teramo K, Widness J, Clemons G, Voutilainen P, McKinlay S, Schwartz R . Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy. Obstet Gynecol. 1987; 69(5):710-6. View

12.

Andropoulos D, Brady K, Easley R, Dickerson H, Voigt R, Shekerdemian L . Erythropoietin neuroprotection in neonatal cardiac surgery: a phase I/II safety and efficacy trial. J Thorac Cardiovasc Surg. 2012; 146(1):124-31. PMC: 3579008. DOI: 10.1016/j.jtcvs.2012.09.046. View

13.

Lynch J, Nelson K . Epidemiology of perinatal stroke. Curr Opin Pediatr. 2001; 13(6):499-505. DOI: 10.1097/00008480-200112000-00002. View

14.

Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M . Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci U S A. 2004; 101(41):14907-12. PMC: 522054. DOI: 10.1073/pnas.0406491101. View

15.

Iwai M, Stetler R, Xing J, Hu X, Gao Y, Zhang W . Enhanced oligodendrogenesis and recovery of neurological function by erythropoietin after neonatal hypoxic/ischemic brain injury. Stroke. 2010; 41(5):1032-7. PMC: 2919308. DOI: 10.1161/STROKEAHA.109.570325. View

16.

Rogers E, Bonifacio S, Glass H, Juul S, Chang T, Mayock D . Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol. 2014; 51(5):657-62. PMC: 4402201. DOI: 10.1016/j.pediatrneurol.2014.08.010. View

17.

McQuillen P, Miller S . Congenital heart disease and brain development. Ann N Y Acad Sci. 2010; 1184:68-86. DOI: 10.1111/j.1749-6632.2009.05116.x. View

18.

Traudt C, McPherson R, Bauer L, Richards T, Burbacher T, McAdams R . Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci. 2013; 35(6):491-503. PMC: 3873854. DOI: 10.1159/000355460. View

19.

Ohls R, Kamath-Rayne B, Christensen R, Wiedmeier S, Rosenberg A, Fuller J . Cognitive outcomes of preterm infants randomized to darbepoetin, erythropoietin, or placebo. Pediatrics. 2014; 133(6):1023-30. PMC: 4531269. DOI: 10.1542/peds.2013-4307. View

20.

Juul S, McPherson R, Bauer L, Ledbetter K, Gleason C, Mayock D . A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics. 2008; 122(2):383-91. DOI: 10.1542/peds.2007-2711. View